|
FY2010
12 months to Dec 31, 2010
|
|
|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |
| Net income | |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| Deferred income tax expense (benefit) | |
| Shortfall tax benefits from stock-based compensation | |
| Depreciation and amortization | |
| Stock-based compensation expense | |
| Changes in fair value of investments | |
| Amortization of debt discount and debt issuance costs | |
| Loss (gain) on foreign exchange contracts | |
| Other | |
| Changes in operating assets and liabilities, net of acquisitions: | |
| Receivables | |
| Inventory | |
| Other assets | |
| Accounts payable, accrued expenses and deferred revenues | |
| Other liabilities | |
| Net cash provided by (used for) operating activities | |
| CASH FLOWS FROM INVESTING ACTIVITIES: | |
| Purchases of property and equipment | |
| Proceeds from sale of property and equipment | |
| Purchases of investments | |
| Acquisition of Mepha GmbH, net of cash acquired | |
| (Cash settlements of) proceeds from foreign exchange contracts | |
| Net cash used for investing activities | |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |
| Proceeds from exercises of common stock options | |
| Windfall tax benefits from stock-based compensation | |
| Acquisition of treasury stock | |
| Acquisition of Ception Therapeutics, Inc. noncontrolling interest | |
| Acquisition of BioAssets Development Corp. noncontrolling interest | |
| Payments on and retirements of long-term debt | |
| Net cash provided by (used for) financing activities | |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | |
| Supplemental disclosures of cash flow information: | |
| Cash payments for interest, net of capitalized interest | |
| Cash payments for income taxes | |
| Non-cash investing and financing activities: | |
| Capital lease additions | |
| Acquisition of treasury stock associated with termination of convertible note hedge and warrant agreements | |
| Exchange of convertible notes into common stock |
Loading...
